Benoit Gourdier - 02 Oct 2023 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott K. Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
02 Oct 2023
Transactions value $
$0
Form type
4
Filing time
04 Oct 2023, 16:40:22 UTC
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Award $0 +16.8K $0.00 16.8K 02 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTR Stock Options (Right to Buy) Award $0 +39.3K $0.00 39.3K 02 Oct 2023 Common Stock 39.3K $20.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of 16,786 restricted stock units that vest in four equal annual installments beginning on October 2, 2024.
F2 Reflects a grant of stock options that vest in four equal annual installments beginning on October 2, 2024.